Abstract:Brain tumor segmentation is an important technique in computer-assisted diagnosis. To improve brain tumor diagnosis, it is necessary to use biochemical information provided by magnetic resonance spectroscopy (MRS). Some of the challenges involved are determining how to combine multimodal signals such as proton MRS and morphological or structural images, then knowing how to use the combined information to make a decision. In this paper, we propose using a data fusion method to perform an automatic segmentation of the brain tumor areas. To diagnose brain tissue abnormalities such as tumors, we need to use multispectral magnetic resonance images (MRIs), e.g. T1-weighted, T2-weighted, gadolinium, or FLAIR to determine some properties of the tumor, including size, position, sort, and relationship with other tissues. However, the tumor type and grade are usually diagnosed from histopathological examination of a surgical specimen. Proton (1H) magnetic resonance spectroscopy (MRS) is a non invasive MR technique that provides biochemical information about metabolites. The major biochemical characteristics can provide useful information about brain tumor type and grade (Howe et al., 2003a; 2003b). In many studies, the use of in vivo 1H-MRS has been described for determining tumor type and grade (Howe et al., 2003a; Howe et al., 2003b; Preul et al., 1996; Majos et al., 2009). Since analysis of in vivo MRS measurements are dependent on acquisition techniques that could compromise the spatial resolution and accuracy of resulting metabolite values (Maudsley et al., 2009), metabolic changes associated with disease are frequently small and diffuse. Furthermore, using the chemical-shift imaging (CSI) technique, metabolite images, known as MR spectroscopic imaging (MRSI) images, can be created using multivoxel MRS information, but it is not as visually interpretable as in a structural MRI (Maudsley et al., 2009). So, for tumor tissue classification, it is important that MRSI be combined with MRI to make a more accurate estimation of variations in metabolites, support hypotheses of metabolite variation causes, and to yield sufficient information about the tissue. For over a decade, scientists have been developing automated brain-tumor classification methods using MRS (Garcia-Gomez et al., 2009), but a more clear definition of brain tumor type and grade may be obtained by combining MRS or MRSI and MRI (Garcia-Gomez et al., 2009). A technique used to differentiate glioblastoma from metastatic lesions using MRI and

Combined 7T CEST/MRS Imaging to Predict Tumor Metabolism in Glioma

Noninvasive Delineation of Glioma Infiltration with Combined 7T Chemical Exchange Saturation Transfer Imaging and MR Spectroscopy: A Diagnostic Accuracy Study

Glial Tumors: Quantification and Segmentation from MRI and MRS

Relationship between multi-pool model-based chemical exchange saturation transfer imaging, intravoxel incoherent motion MRI, and 11C-methionine uptake on PET/CT in patients with gliomas

Combination of Magnetic Resonance Spectroscopy and 11C-Methionine Positron Emission Tomography for the Accurate Diagnosis of Non-Enhancing Supratentorial Glioma

Metabolic Approach for Tumor Delineation in Glioma Surgery: 3d Mr Spectroscopy Image-Guided Resection

Imaging of increased peritumoral glutamate and glutamine in gliomas using 7T MRSI

Application of 7T MRS to High-Grade Gliomas

A Comparison of 7 Tesla MR Spectroscopic Imaging and 3 Tesla MR Fingerprinting for Tumor Localization in Glioma Patients

Magnetic resonance spectroscopic imaging in gliomas: clinical diagnosis and radiotherapy planning

Combination of Magnetic Resonance Spectroscopy and 11C-methionine PET in Early Diagnosis of Non-enhancing Supratentorial Glioma

Combination of Proton MR Spectroscopy and Diffusion-Weighted (DW) Imaging in the Evaluation of Common Intracranial Tumors

Magnetic Resonance Spectroscopic and Perfusion MRI in High Grade Gliomas and Metastases

Brain Tumor Segmentation through Data Fusion of T2-Weighted Image and MR Spectroscopy

Relation between MRS and Glioma Metabolism Boundary

Multimodal imaging in cerebral gliomas and its neuropathological correlation

Application Of Magnetic Resonance Spectroscopy In The Preoperative Grading Of Gliomas

Glioma Tissue Modeling by Combing the Information of MRI and in Vivo Multivoxel MRS

Direct Radiofrequency Saturation Corrected Amide Proton Transfer Tumor MRI at 3T

[Metabolic studies of gliomas with positron emission tomography and phosphorus 31 MR spectroscopy in diagnosis and treatment planning]